written by Michael O’Leary
Good news, bad news for people taking new class of type 2 diabetes drugs…
People with type 2 diabetes who take one of the newer add-on drugs have been whipsawed by the news this past week that on the one hand their drugs might lower their risk of being hospitalized for heart failure, while on the other the drugs might increase their risk of pancreatitis.